Beximco Pharmaceuticals Limited (DSE:BXPHARMA)

Beximco Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 9, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	42,648	52,686	65,222	68,969	79,096	28,065
Market Cap Growth	-44.19%	-19.22%	-5.43%	-12.80%	181.83%	-17.13%
Enterprise Value	49,942	62,322	79,259	84,113	87,267	38,810
Last Close Price	95.60	112.26	135.64	140.02	157.97	55.48
PE Ratio	6.71	9.04	14.14	13.46	15.43	7.99
Forward PE	7.53	12.33	12.33	10.83	16.20	9.47
PS Ratio	0.92	1.19	1.66	1.99	2.68	1.10
PB Ratio	0.80	1.01	1.37	1.55	2.12	0.86
P/TBV Ratio	0.96	1.24	1.70	1.96	2.25	0.92
P/FCF Ratio	-	8.27	17.75	28.75	22.58	8.51
P/OCF Ratio	-	6.30	10.72	13.23	13.13	5.06
PEG Ratio	-	0.67	0.67	0.68	0.65	0.65
EV/Sales Ratio	1.08	1.40	2.02	2.43	2.96	1.52
EV/EBITDA Ratio	4.71	6.25	8.84	10.20	11.70	5.98
EV/EBIT Ratio	5.67	7.52	11.48	12.78	13.75	7.22
EV/FCF Ratio	12.20	9.78	21.57	35.06	24.92	11.76
Debt / Equity Ratio	0.12	0.12	0.22	0.28	0.20	0.32
Debt / EBITDA Ratio	0.58	0.60	1.18	1.50	1.02	1.62
Debt / FCF Ratio	1.51	0.95	2.89	5.16	2.18	3.18
Asset Turnover	0.64	0.64	0.58	0.59	0.58	0.52
Inventory Turnover	1.77	1.87	1.77	1.91	2.03	1.91
Quick Ratio	0.60	0.52	0.37	0.35	0.39	0.35
Current Ratio	2.13	2.18	1.57	1.45	1.47	1.15
Return on Equity (ROE)	12.45%	11.79%	9.81%	12.19%	14.72%	11.31%
Return on Assets (ROA)	7.62%	7.48%	6.38%	6.95%	7.75%	6.76%
Return on Capital (ROIC)	9.45%	8.92%	7.49%	8.06%	8.98%	7.75%
Return on Capital Employed (ROCE)	14.10%	13.90%	12.30%	12.30%	14.80%	13.90%
Earnings Yield	14.90%	11.06%	7.07%	7.43%	6.48%	12.52%
FCF Yield	9.60%	12.09%	5.63%	3.48%	4.43%	11.76%
Dividend Yield	4.18%	3.56%	2.58%	2.50%	2.22%	2.46%
Payout Ratio	28.09%	27.21%	33.98%	31.68%	11.28%	17.13%
Total Shareholder Return	4.18%	3.56%	2.58%	2.50%	2.22%	2.46%

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.